News
CDXS
1.740
+6.75%
0.110
Codexis (CDXS) Gets a Buy from Jefferies
TipRanks · 15h ago
Weekly Report: what happened at CDXS last week (0323-0327)?
Weekly Report · 2d ago
Weekly Report: what happened at CDXS last week (0316-0320)?
Weekly Report · 03/23 10:32
Weekly Report: what happened at CDXS last week (0309-0313)?
Weekly Report · 03/16 10:31
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue Guidance - Has The Bull Case Changed?
Simply Wall St · 03/15 15:13
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement
Simply Wall St · 03/14 13:29
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT)
TipRanks · 03/13 08:30
Craig-Hallum Sticks to Its Buy Rating for Codexis (CDXS)
TipRanks · 03/13 08:15
Codexis Earnings Call: ECOsynthesis Momentum Amid Risks
TipRanks · 03/13 00:03
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative
Simply Wall St · 03/12 22:34
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform
Seeking Alpha · 03/12 17:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 03/12 17:05
Thursday Sector Leaders: Oil & Gas Refining & Marketing, Chemicals
NASDAQ · 03/12 16:14
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall
Benzinga · 03/12 13:49
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
TipRanks · 03/12 13:00
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 03/12 12:05
Codexis rises after Q4 beat, strong outlook
Seeking Alpha · 03/12 11:39
Codexis Jumps On Q4 Results, Expects 2-8% Revenue Growth In FY'26
NASDAQ · 03/12 10:56
Why Petco Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 03/12 09:28
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours?
Benzinga · 03/12 05:25
More
Webull provides a variety of real-time CDXS stock news. You can receive the latest news about Codexis Inc through multiple platforms. This information may help you make smarter investment decisions.
About CDXS
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.